Cost |
Generate economies of scale: high-throughput sample processing; |
Instrument access |
Use of core facilities; negotiations with suppliers. |
Comparability |
Using Sanger mimic conditions with conservative thresholds (20%) to report DRMs; Recommendations of the First “Winnipeg Consensus” [10]. |
Bioinformatics and data analysis |
Specialized, freely available, or low-cost pipelines. |
Personnel training/retention |
Support of laboratories within WHO HIVResNet. Support from instrument manufacturers and suppliers. |
Quality assurance |
Support from WHO HIVResNet; Search for additional support from other leading international agencies, such as the Public Health Agency of Canada or the US Centers for Disease Control and Prevention. |